IDH1 and central nervous system cancer: Gliomas in orthotopic syngeneic glioma mouse models bearing the IDH1 mutation compared with gliomas in mice wild type (WT) for IDH1 also have reduced tumor-infiltrating cytotoxic T cells, as well as reduced chemokine CXCL10 expression and reduced STAT1-positive cells.